BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Cornerstone Therapeutics Inc. 

2000 Regency Parkway
Suite 255
Cary  North Carolina  27518  U.S.A.
Phone: 888-466-6505 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Cornerstone Therapeutics Inc. Receives CARDENE(R) I.V. (Nicardipine Hydrochloride) Paragraph IV Notice Letter 6/13/2013 10:04:55 AM    More...
Cornerstone Therapeutics Inc. Reports First Quarter 2013 Financial Results 5/9/2013 11:04:23 AM    More...
Cornerstone Therapeutics Inc. Acquires Exclusive U.S. Marketing Rights to PERTZYE® (pancrelipase) for Treatment of Exocrine Pancreatic Insufficiency in Patients With Cystic Fibrosis 5/9/2013 11:02:17 AM    More...
Cornerstone Therapeutics Inc. to Host First Quarter 2013 Conference Call 5/3/2013 10:54:09 AM    More...
Cornerstone Therapeutics Inc. Announces Retention of Advisors 3/21/2013 9:47:19 AM    More...
Cornerstone Therapeutics Inc. Reports Fourth Quarter and Fiscal Year 2012 Financial Results 3/14/2013 9:18:16 AM    More...
Cornerstone Therapeutics Inc. to Host Fourth Quarter and Full Year 2012 Conference Call 3/8/2013 8:41:32 AM    More...
Cornerstone Therapeutics Inc. Announces Appointment of Special Committee 2/26/2013 9:25:57 AM    More...
Cornerstone Therapeutics Inc. Announces Receipt of Take-Private Proposal From Its Majority Stockholder 2/20/2013 9:16:03 AM    More...
Cornerstone Therapeutics Inc. Acquires Exclusive U.S. Rights to Chiesi Farmaceutici SpA's BETHKIS® (Tobramycin Inhalation Solution) 11/8/2012 9:21:39 AM    More...
123456789